Cargando…
Performance of chromosomal microarray for patients with intellectual disabilities/developmental delay, autism, and multiple congenital anomalies in a Chinese cohort
BACKGROUND: Chromosomal microarray (CMA) is currently the first-tier genetic test for patients with idiopathic neuropsychiatric diseases in many countries. Its improved diagnostic yield over karyotyping and other molecular testing facilitates the identification of the underlying causes of neuropsych...
Autores principales: | Chong, Wilson Wai Sing, Lo, Ivan Fai Man, Lam, Stephen Tak Sum, Wang, Chi Chiu, Luk, Ho Ming, Leung, Tak Yeung, Choy, Kwong Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055236/ https://www.ncbi.nlm.nih.gov/pubmed/24926319 http://dx.doi.org/10.1186/1755-8166-7-34 |
Ejemplares similares
-
Chromosomal Microarray Testing in 42 Korean Patients with Unexplained Developmental Delay, Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies
por: Lee, Sun Ho, et al.
Publicado: (2017) -
Chromosomal microarray in clinical diagnosis: a study of 337 patients with congenital anomalies and developmental delays or intellectual disability
por: Sansović, Ivona, et al.
Publicado: (2017) -
Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions
por: Fan, Yanjie, et al.
Publicado: (2018) -
Chromosomal microarray analysis of 410 Han Chinese patients with autism spectrum disorder or unexplained intellectual disability and developmental delay
por: Liu, Yi, et al.
Publicado: (2022) -
Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability
por: Lee, Jin Sook, et al.
Publicado: (2018)